BRIEF-Expert Systems and Traws Pharma Report Breakthrough in H5N1Bird Flu Antiviral Program
ReutersJan 10, 2025 11:17 PM
Jan 10 (Reuters) - Traws Pharma Inc TRAW.O:
EXPERT SYSTEMS: ANNOUNCED A SIGNIFICANT MILESTONE IN A DEVELOPMENT OF TRAWS PHARMA'S H5N1 ANTIVIRAL PROGRAM
EXPERT SYSTEMS: WITH COMPLETION OF PHASE 1 TRIALS, PLANS ARE UNDERWAY TO INITIATE PHASE 2 EFFICACY STUDIES IN FIRST HALF OF 2025
Source text: ID:nPn6sWG9ma
Further company coverage: TRAW.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
Nike’s Playbook Faces Real Pressure
TradingKey - In a year where global sports brands face inventory builds and fluid consumer behavior, Nike’s (NKE) recent earnings release reveals an uncomfortable reality: even an icon is not immune to cyclical drag and self-generated execution risk. Revenues fell 10% to $46.3 billion for fiscal...TradingKey
Fri, Jul 4
Tesla Delivery Still Weak, but AI Remains the Long Game
TradingKey - Tesla’s Q2 2025 results didn’t wow the Street. The company produced around 410,000 vehicles and delivered roughly 384,000—slightly better than expected, but still down significantly year-over-year.TradingKey
Fri, Jul 4
Prediction! Federal Reserve Chairman Jerome Powell's Next Move Will Be an Interest Rate Cut
The Federal Reserve must balance the risks of higher inflation with the risks of higher unemployment when making decisions on interest rates.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »*Stock prices used were..The Motley Fool
Thu, Jun 26
What is the Future of Stablecoins? Here are Some Stablecoin Stocks to Watch
With regulations solidifying, institutional money flowing in, and global market expansion accelerating, stablecoin-related stocks could experience unprecedented growth.TradingKey
Wed, Jun 11
Will Trump’s Tax Bill Benefit American Citizens? 3 Major Controversies: SALT, Medicaid Cuts, and Fiscal Deficits
TradingKey - Key questions remain: Does the U.S. still have room for further tax cuts amid its massive fiscal deficit? Will adjustments to the State and Local Tax (SALT) cap truly benefit ordinary Americans or merely enrich the wealthy? Can Congress and society accept the welfare cuts? Will the...TradingKey
Fri, May 23
Tradingkey
